» Articles » PMID: 19931185

Feline Programmed Death and Its Ligand: Characterization and Changes with Feline Immunodeficiency Virus Infection

Overview
Date 2009 Nov 26
PMID 19931185
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Programmed death (PD)-1 and its ligand, PD-L1, are co-stimulatory molecules expressed on T cells and antigen-presenting cells, respectively, that modulate T cell receptor signals. Altered PD expression or signalling contributes to pathogen persistence in chronic infections. The sequence of the feline PD genes was derived from gene amplification with primers conserved across human and canine homologs, and by sequence extension through rapid amplification of cDNA ends. Feline PD-1 was similar to that of other mammalian species and consisted of extracellular, transmembrane and cytoplasmic regions. Functional motif analysis of the translated amino acid sequence predicted immunoreceptor tyrosine-based inhibitory and switch motifs, and a SH3-binding region, in the cytoplasmic tail. PD-1 and PD-L1 were expressed in resting lymphocytes and dendritic cells, and up-regulated on mitogen-activated or irradiated lymphocytes of both CD4 and CD8-positive subsets. In vitro infection with the feline immunodeficiency virus (FIV) significantly decreased PD-1, but not PD-L1, gene expression in lymphocytes at 24h, and decreased expression of both genes at 168h. No significant changes in gene or protein expression from FIV infection were noted in dendritic cells. Blood lymphocytes from cats chronically FIV-infected expressed significantly higher PD protein than lymphocytes from FIV-negative cats. These findings indicate that both feline PD-1 and PD-L1 are expressed by resting lymphocytes and dendritic cells. Apoptosis and cell activation increased protein expression on lymphocytes, while in vitro acute FIV infection decreased PD-1 gene expression. Increased PD levels in lymphocytes from chronically FIV-infected cats suggests that alterations in T cell co-signalling may contribute to immune dysfunction in lentiviral infection.

Citing Articles

Cross-reactivity of anti-human programmed cell death ligand 1 (PD-L1) monoclonal antibody, clone 28-8 against feline PD-L1.

Nishibori S, Sakurai M, Kagawa Y, Uchida K, Nakagawa T, Igase M J Vet Med Sci. 2023; 85(6):592-600.

PMID: 37150603 PMC: 10315546. DOI: 10.1292/jvms.23-0003.


Development of anti-feline PD-1 antibody and its functional analysis.

Nishibori S, Kaneko M, Nakagawa T, Nishigaki K, Kato Y, Igase M Sci Rep. 2023; 13(1):6420.

PMID: 37095139 PMC: 10126011. DOI: 10.1038/s41598-023-31543-6.


Molecular characterization of feline immune checkpoint molecules and establishment of PD-L1 immunohistochemistry for feline tumors.

Maekawa N, Konnai S, Asano Y, Otsuka T, Aoki E, Takeuchi H PLoS One. 2023; 18(1):e0281143.

PMID: 36701405 PMC: 9879432. DOI: 10.1371/journal.pone.0281143.


The PD-1/PD-L1 Pathway: A Perspective on Comparative Immuno-Oncology.

Schoniger S, Jasani B Animals (Basel). 2022; 12(19).

PMID: 36230402 PMC: 9558501. DOI: 10.3390/ani12192661.


Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.

Flies A, Blackburn N, Lyons A, Hayball J, Woods G Front Immunol. 2017; 8:513.

PMID: 28515726 PMC: 5413580. DOI: 10.3389/fimmu.2017.00513.